线祖利德的结构性毒性关系 (STR) 减轻骨髓抑制和血清毒性毒性
1Division of Computer Aided Drug Design, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule 425405, Maharashtra, India; Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule 425405, Maharashtra, India.
研究人员探索了对重要结核病药物Linezolid的修改,以减少诸如骨髓抑制等副作用. 新的类似物显示出对抗多药耐药结核病的更安全,更有效的治疗有希望.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 是一个主要的全球卫生问题,由多抗药性 (MDR-TB) 和广泛抗药性 (XDR-TB) 菌株加剧.
- 在BPaL疗法中,线索利德对于治疗MDR-TB和XDR-TB至关重要,但会导致骨髓抑制和单胺氧化酶 (MAO) 抑制.
- 了解Linezolid的结构毒性关系 (STR) 对于开发更安全的替代品至关重要.
研究的目的:
- 研究Linezolid及其类型的结构毒性关系 (STR).
- 为了确定减少Linezolid的毒性 (骨髓抑制,MAO抑制) 的修改,同时保持抗菌功效.
- 探索开发更安全的oxazolidinone衍生物治疗耐药结核病的潜力.
主要方法:
- 对Linezolid类似物进行结构毒性关系 (STR) 分析.
- 专注于佐利丁核心的C环和C-5位置的修改.
- 评估新型化合物的抗菌活性和毒性概况 (骨髓抑制,MAO抑制).
主要成果:
- 几种Linezolid类似物显示减少了骨髓抑制和MAO抑制.
- 这些修改显示了对抗耐药结核病菌株的抗菌活性保持或增强的潜力.
- 已经确定了对更安全的Linezolid衍生物有希望的候选者.
结论:
- 继续对佐利丁STR进行研究对于改善药物安全至关重要.
- 开发更安全的Linezolid类似物可以增强耐药结核病的治疗选择.
- 有针对性的结构修改提供了一种可行的策略,以减轻Linezolid的不良影响.
更多相关视频
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
